Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Tang

Showing results (191-200 of 255) with videos related to

Pageof 26
Sort By:
Nature Medicine|January 22, 2025
The Access to Dialysis in Low- and Middle-Income Countries Commission: lessons for universal health coverageYot Teerawattananon, Kinanti Khansa Chavarina, Jeerath Phannajit, et al.
Nephrology (Carlton, Vic.)|April 22, 2017
Mycobacterium chlorophenolicum: An uncommon cause of peritonitis in a peritoneal dialysis patientGary C W Chan, Maggie M Y Mok, Derek L L Hung, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 4, 2020
Direct Renin Inhibition in Non-diabetic chronic Kidney disease (DRINK): a prospective randomized trialSydney C W Tang, Kam Wa Chan, Dennis K M Ip, et al.
Kidney International|November 5, 2015
Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stressWai Han Yiu, Dickson W L Wong, Hao Jia Wu, et al.
Frontiers in Endocrinology|December 11, 2024
Association of systemic immune-inflammation index with all-cause and cardio-cerebrovascular mortality in individuals with diabetic kidney disease: evidence from NHANES 1999-2018Manhuai Zhang, Siyang Ye, Jianbo Li, et al.
Kidney International|January 23, 2019
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceJürgen Floege, Sean J Barbour, Daniel C Cattran, et al.
Cell Death & Disease|March 25, 2016
Downregulation of renal tubular Wnt/β-catenin signaling by Dickkopf-3 induces tubular cell death in proteinuric nephropathyD W L Wong, W H Yiu, H J Wu, et al.
Clinical Science (London, England : 1979)|October 20, 2020
The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosisSarah W Y Lok, Wai Han Yiu, Hongyu Li, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 7, 2025
Urinary Albumin-to-Creatinine Ratio, Cardiovascular Health, and All-Cause Mortality in Hypertension: A Nationwide Cohort AnalysisDingding Wang, Meng Zhang, Peichen Xie, et al.
Kidney International|September 1, 2023
Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney diseaseKam Wa Chan, J David Smeijer, Meir Schechter, et al.
Pageof 26

Showing results (191-200 of 255) with videos related to

Sort By:
Pageof 26
Nature Medicine|January 22, 2025
The Access to Dialysis in Low- and Middle-Income Countries Commission: lessons for universal health coverageYot Teerawattananon, Kinanti Khansa Chavarina, Jeerath Phannajit, et al.
Nephrology (Carlton, Vic.)|April 22, 2017
Mycobacterium chlorophenolicum: An uncommon cause of peritonitis in a peritoneal dialysis patientGary C W Chan, Maggie M Y Mok, Derek L L Hung, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 4, 2020
Direct Renin Inhibition in Non-diabetic chronic Kidney disease (DRINK): a prospective randomized trialSydney C W Tang, Kam Wa Chan, Dennis K M Ip, et al.
Kidney International|November 5, 2015
Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stressWai Han Yiu, Dickson W L Wong, Hao Jia Wu, et al.
Frontiers in Endocrinology|December 11, 2024
Association of systemic immune-inflammation index with all-cause and cardio-cerebrovascular mortality in individuals with diabetic kidney disease: evidence from NHANES 1999-2018Manhuai Zhang, Siyang Ye, Jianbo Li, et al.
Kidney International|January 23, 2019
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceJürgen Floege, Sean J Barbour, Daniel C Cattran, et al.
Cell Death & Disease|March 25, 2016
Downregulation of renal tubular Wnt/β-catenin signaling by Dickkopf-3 induces tubular cell death in proteinuric nephropathyD W L Wong, W H Yiu, H J Wu, et al.
Clinical Science (London, England : 1979)|October 20, 2020
The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosisSarah W Y Lok, Wai Han Yiu, Hongyu Li, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 7, 2025
Urinary Albumin-to-Creatinine Ratio, Cardiovascular Health, and All-Cause Mortality in Hypertension: A Nationwide Cohort AnalysisDingding Wang, Meng Zhang, Peichen Xie, et al.
Kidney International|September 1, 2023
Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney diseaseKam Wa Chan, J David Smeijer, Meir Schechter, et al.
Pageof 26